Related Experiment Video
Updated: Aug 9, 2026
08:29
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study
L A Pfeifer1, L R White, G W Ross
1Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging/NIH, 7201 Wisconsin Avenue, Bethesda, MD 20892, USA.
Neurology
|June 12, 2002
Summary
Cerebral amyloid angiopathy (CAA) may worsen cognitive decline in men with Alzheimer's disease (AD). Combined CAA and AD led to significantly lower cognitive scores compared to AD alone.
Area of Science:
- Neurology
- Pathology
- Gerontology
Background:
- Cerebral amyloid angiopathy (CAA) is a vascular pathology associated with aging and neurodegenerative diseases.
- The interplay between CAA, Alzheimer's disease (AD), and cognitive decline requires further investigation.
Purpose of the Study:
- To examine the relationship between cerebral amyloid angiopathy (CAA), dementia, and cognitive function.
- To assess the impact of CAA on cognitive impairment in Japanese-American men.
Main Methods:
- Autopsy-based study of 211 Japanese-American men from the Honolulu-Asia Aging Study.
- Neuropathological examination for CAA, neurofibrillary tangles (NFT), and neuritic plaques (NP).
- Cognitive function assessed using the Cognitive Abilities Screening Instrument (CASI); dementia diagnosed using established criteria.
Main Results:
- 44.1% of subjects exhibited CAA in neocortical areas.
- CAA presence correlated with higher NFT and NP counts and APOE-epsilon4 allele.
- Men with both AD and CAA showed a 45.9% lower CASI score compared to nondemented men without CAA.
Conclusions:
- CAA may exacerbate cognitive impairment in dementia, particularly in Alzheimer's disease.
- The interaction between CAA and AD pathology leads to more severe cognitive decline.
- Findings highlight CAA as a significant contributor to dementia severity.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...